Literature DB >> 23964033

Long-term outcomes and cardiac surgery in critically ill patients with infective endocarditis.

Mariana Mirabel1, Romain Sonneville, David Hajage, Emmanuel Novy, Florence Tubach, Philippe Vignon, Pierre Perez, Sylvain Lavoué, Achille Kouatchet, Olivier Pajot, Armand Mekontso-Dessap, Jean-Marie Tonnelier, Pierre-Edouard Bollaert, Jean-Pierre Frat, Jean-Christophe Navellou, Herve Hyvernat, Ali Ait Hssain, Jean-François Timsit, Bruno Megarbane, Michel Wolff, Jean-Louis Trouillet.   

Abstract

AIMS: To assess long-term outcomes and the management of critical left-sided infective endocarditis (IE) and evaluate the impact of surgery. METHODS AND
RESULTS: Among the 198 patients included prospectively for IE across 33 adult intensive care units (ICU) in France from 1 April 2007 to 1 October 2008, 137 (69%) were dead at a median follow-up time of 59.5 months. Characteristics significantly associated with mortality were: Sepsis-related Organ-Failure Assessment (SOFA) score at ICU admission [Hazard ratio (HR), 95% Confidence Interval (CI) of 1.43 (0.79-2.59) for SOFA 5-9; 2.01 (1.05-3.85) for SOFA 10-14; 3.53 (1.75-7.11) for SOFA 15-20; reference category SOFA 0-4; P = 0.003]; prosthetic mechanical valve IE [HR 2.01; 95% CI 1.09-3.69, P = 0.025]; vegetation size ≥15 mm [HR 1.64; 95% CI 1.03-2.63, P = 0.038]; and cardiac surgery [HR (95%CI), 0.33 (0.16-0.67) for surgery ≤1 day after IE diagnosis; 0.61 (0.29-1.26) for surgery 2-7 days after IE diagnosis; 0.42 (0.21-0.83) for surgery >7 days after IE diagnosis; reference category no surgery; P = 0.005]. One hundred and three (52%) patients underwent cardiac surgery after a median time of 6 (16) days. Independent predictors of surgical intervention on multivariate analysis were: age ≤60 years [Odds ratio (OR) 5.30; 95% CI (2.46-11.41), P < 0.01], heart failure [OR 3.27; 95% CI (1.03-10.35), P = 0.04], cardiogenic shock [OR 3.31; 95% CI (1.47-7.46), P = 0.004], septic shock [OR 0.25; 95% CI (0.11-0.59), P = 0.002], immunosuppression [OR 0.15; 95% CI (0.04-0.55), P = 0.004], and diagnosis before or within 24 h of ICU admission [OR 2.81; 95% CI (1.14-6.95), P = 0.025]. SOFA score calculated the day of surgery was the only independently associated factor with long-term mortality [HR (95% CI) 1.59 (0.77-3.28) for SOFA 5-9; 3.56 (1.71-7.38) for SOFA 10-14; 11.58 (4.02-33.35) for SOFA 15-20; reference category SOFA 0-4; P < 0.0001]. Surgical timing was not associated with post-operative outcomes. Of the 158 patients with a theoretical indication for surgery, the 58 deemed not fit had a 95% mortality rate.
CONCLUSION: Mortality in patients with critical IE remains unacceptably high. Factors associated with long-term outcomes are the severity of multiorgan failure, prosthetic mechanical valve IE, vegetation size ≥15 mm, and surgical treatment. Up to one-third of potential candidates do not undergo surgery and these patients experience extremely high mortality rates. The strongest independent predictor of post-operative mortality is the pre-operative multiorgan failure score while surgical timing does not seem to impact on outcomes.

Entities:  

Keywords:  Heart valve disease; Intensive care; Valve surgery

Mesh:

Year:  2013        PMID: 23964033     DOI: 10.1093/eurheartj/eht303

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  23 in total

1.  [Infective endocarditis].

Authors:  D Horstkotte; C Piper
Journal:  Herz       Date:  2015-04       Impact factor: 1.443

2.  What's new in surgical treatment of infective endocarditis?

Authors:  Thierry Carrel; Lars Englberger; Jukka Takala
Journal:  Intensive Care Med       Date:  2016-09-23       Impact factor: 17.440

3.  Risk prediction in infective endocarditis by modified MELD-XI score.

Authors:  Peng-Cheng He; Xue-Biao Wei; Si-Ni Luo; Xiao-Lan Chen; Zu-Hui Ke; Dan-Qing Yu; Ji-Yan Chen; Yuan-Hui Liu; Ning Tan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-03-29       Impact factor: 3.267

4.  Infective endocarditis and outcomes of valve surgery: the bug, the valve, the host and the unknown.

Authors:  Sudarshan Balla; Mohamad Alkhouli
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

5.  My paper 10 years later: infective endocarditis in the intensive care unit.

Authors:  Michel Wolff; Bruno Mourvillier; Romain Sonneville; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2014-09-20       Impact factor: 17.440

Review 6.  Neurologic Complications of Infective Endocarditis: Recent Findings.

Authors:  Marie Cantier; Mikael Mazighi; Isabelle Klein; J P Desilles; Michel Wolff; J F Timsit; Romain Sonneville
Journal:  Curr Infect Dis Rep       Date:  2017-09-19       Impact factor: 3.725

7.  Infective endocarditis on ICU: risk factors, outcome and long-term follow-up.

Authors:  A Samol; S Kaese; J Bloch; D Görlich; G Peters; J Waltenberger; H Baumgartner; H Reinecke; P Lebiedz
Journal:  Infection       Date:  2015-01-10       Impact factor: 3.553

8.  Impact of Valve Culture Positivity on Prognosis in Patients with Infective Endocarditis Who Underwent Valve Surgery.

Authors:  Jinnam Kim; Jung Ho Kim; Hi Jae Lee; Se Ju Lee; Ki Hyun Lee; Eun Hwa Lee; Yae Jee Baek; Jin Young Ahn; Su Jin Jeong; Nam Su Ku; Seung Hyun Lee; Jun Yong Choi; Joon-Sup Yeom
Journal:  Infect Dis Ther       Date:  2022-04-30

9.  Infective endocarditis in the Pacific: clinical characteristics, treatment and long-term outcomes.

Authors:  Mariana Mirabel; Romain André; Paul Barsoum Mikhaïl; Hester Colboc; Flore Lacassin; Baptiste Noël; Jacques Robert; Marie Nadra; Corinne Braunstein; Shirley Gervolino; Eloi Marijon; Bernard Iung; Xavier Jouven
Journal:  Open Heart       Date:  2015-04-30

10.  Outcomes and Risk Factors of Septic Shock in Patients With Infective Endocarditis: A Prospective Cohort Study.

Authors:  Juan M Pericàs; Marta Hernández-Meneses; Patricia Muñoz; Ana Álvarez-Uría; Blanca Pinilla-Llorente; Arístides de Alarcón; Karlos Reviejo; M Carmen Fariñas; Carlos Falces; Josune Goikoetxea-Agirre; Juan Gálvez-Acebal; Carmen Hidalgo-Tenorio; Eloy Gómez-Nebreda; Jose M Miro
Journal:  Open Forum Infect Dis       Date:  2021-03-25       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.